Drug Shortage Report for TEVA-TENOFOVIR

Last updated on 2022-12-15 History
Report ID 155186
Drug Identification Number 02403889
Brand name TEVA-TENOFOVIR
Common or Proper name TENOFOVIR DISO FUM 300MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-16
Estimated end date 2022-12-30
Actual end date 2022-12-14
Shortage status Resolved
Updated date 2022-12-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2022-12-15 French Compare
v19 2022-12-15 English Compare
v18 2022-12-01 French Compare
v17 2022-12-01 English Compare
v16 2022-09-07 French Compare
v15 2022-09-07 English Compare
v14 2022-08-18 French Compare
v13 2022-08-18 English Compare
v12 2022-08-08 French Compare
v11 2022-08-08 English Compare
v10 2022-05-19 French Compare
v9 2022-05-19 English Compare
v8 2022-04-21 French Compare
v7 2022-04-21 English Compare
v6 2022-03-17 French Compare
v5 2022-03-17 English Compare
v4 2022-03-09 French Compare
v3 2022-03-09 English Compare
v2 2022-02-17 French Compare
v1 2022-02-17 English Compare

Showing 1 to 20 of 20